Antonio
Pineda Lucena
Investigador Senior
Hospital General Universitario de Valencia
Valencia, EspañaHospital General Universitario de Valencia -ko ikertzaileekin lankidetzan egindako argitalpenak (2)
2023
-
Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer
Nature Communications, Vol. 14, Núm. 1
2016
-
Serum metabolomic profiling facilitates the non-invasive identification of metabolic biomarkers associated with the onset and progression of non-small cell lung cancer
Oncotarget, Vol. 7, Núm. 11, pp. 12904-12916